US FDA Implementing Hybrid Work Policy In January

Agency employees will have on-site, telework and remote possibilities, but options will depend on the center, office and job duties.

FDA hybrid work — Individual duties will help determine whether on-site, telework and remote working options will be available for FDA employees. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

The US Food and Drug Administration will not require all employees to resume their daily treks to the office going forward, choosing a “hybrid workplace model” that will go into effect in January 2023.

Commissioner Robert Califf made the change after the agency completed a six-month pilot exploring workplace flexibilities. The FDA said the...

US FDA Implementing Hybrid Work Policy In January

More from US FDA

More from Agency Leadership